Phospholipid composition of postmortem schizophrenic brain by 31P NMR spectroscopy (Q37029108)

17 August 2017

Phospholipid composition of postmortem schizophrenic brain by 31P NMR spectroscopy (English)

1 reference

17 August 2017

0 references

0 references

John M Pearce

1

1 reference

17 August 2017

Richard A Komoroski

series ordinal

2

1 reference

17 August 2017

Robert E Mrak

series ordinal

3

1 reference

17 August 2017

1 January 2009

1 reference

Magnetic Resonance in Medicine

17 August 2017

1 reference

17 August 2017

61

1 reference

17 August 2017

1

1 reference

17 August 2017

28-34

1 reference

Metabolomic mapping of atypical antipsychotic effects in schizophrenia.

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2610237

Antipsychotic-associated neuronal changes in the brain: toxic, therapeutic, or irrelevant to the long-term outcome of schizophrenia?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2610237

Biochemical alterations of erythrocytes as an indicator of mental disorders: an overview

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2610237

Phosphorus magnetic resonance spectroscopy: its utility in examining the membrane hypothesis of schizophrenia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2610237

Is schizophrenia a metabolic brain disorder? Membrane phospholipid dysregulation and its therapeutic implications

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2610237

Smoking, gender, and dietary influences on erythrocyte essential fatty acid composition among patients with schizophrenia or schizoaffective disorder

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2610237

The human brain revisited: opportunities and challenges in postmortem studies of psychiatric disorders

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2610237

Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2610237

Choline acetyltransferase in schizophrenia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2610237

The membrane hypothesis of schizophrenia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2610237

Lipid composition of the normal human brain: gray matter, white matter, and myelin

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2610237

Diagnostic Criteria for Use in Psychiatric Research

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2610237

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2610237

Phosphorus NMR analysis of phospholipids in detergents

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2610237

Increased phospholipase A2 activity in schizophrenia with absent response to niacin

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2610237

Proton magnetic resonance spectroscopic imaging of cortical gray and white matter in schizophrenia

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2610237

Increased platelet membrane lysophosphatidylcholine in schizophrenia

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2610237

31P NMR spectroscopy of phospholipid metabolites in postmortem schizophrenic brain

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2610237

Sub-chronic antipsychotic drug treatment does not alter brain phospholipid fatty acid composition in rats

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2610237

Validation of quantitative NMR.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2610237

Altered thalamic membrane phospholipids in schizophrenia: a postmortem study

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2610237

Effects of antipsychotic treatment on membrane phospholipid metabolism in schizophrenia

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2610237

Phospholipid patterns of erythrocytes in schizophrenia: relationships to symptomatology.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2610237

Phospholipid abnormalities in postmortem schizophrenic brains detected by 31P nuclear magnetic resonance spectroscopy: a preliminary study

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2610237

In vitro 1H-magnetic resonance spectroscopy of postmortem brains with schizophrenia

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2610237

Increased platelet phospholipase A2 activity in schizophrenia.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2610237

Increased turnover of platelet phosphatidylinositol in schizophrenia

4 September 2018

1 reference

12 December 2020

Increased concentrations of phosphatidylinositol (PI) and decreased esterification of arachidonic acid into phospholipids in platelets from patients with schizoaffective disorders or atypic phasic psychoses

1 reference

12 December 2020

Resolution of phospholipid molecular species by 31P NMR

1 reference

12 December 2020

Plasma membrane phospholipid and cholesterol distribution of skin fibroblasts from drug-naive patients at the onset of psychosis

1 reference

12 December 2020

Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients

1 reference

12 December 2020

Analysis of phospholipid molecular species in brain by (31)P NMR spectroscopy

1 reference

12 December 2020

Phospholipids and calcium alterations in platelets of schizophrenic patients

1 reference

12 December 2020

Changes in the lipid phase of erythrocyte membranes in patients with paranoid schizophrenia

1 reference

12 December 2020

Identifiers

DOI

10.1002/MRM.21820

1 reference

17 August 2017

1 reference

17 August 2017

PubMed publication ID

19097198

1 reference